Vp4 and Baseline Varices Data in IMbrave 150: Clinical Implications

Medical experts analyze the exploratory efficacy and safety results for patients with portal vein invasion (Vp4), addressing the challenges in treating this subgroup.

EP: 1.IMbrave 150: Overview

EP: 2.IMbrave 150: Patient Characteristics

EP: 3.IMbrave 150: Updated Outcomes

EP: 4.Using Atezolizumab + Bevacizumab in Practice

Now Viewing

EP: 5.Vp4 and Baseline Varices Data in IMbrave 150: Clinical Implications

EP: 6.AE Management with Atezolizumab + Bevacizumab

Video content above is prompted by the following:

• Please share your thoughts on the exploratory efficacy and safety results of patients with Vp4.
• Why might this be a challenging population to treat?

Recent Videos